Funding

HHSN272201000039I, Task A21 (J. Morrey - PI)

01/19/11 - 01/18/16

NIAID/NIH
Small Animal Models for Biodefense Viruses and Prions

IDSEP100006-01-00 (B. Tarbet - PI)

09/30/10 - 09/29/15

NIAID/NIH
Influenza Vaccine Biomanufacturing Training

HHSN272201000039I, Task A19 (J. Morrey - PI)

09/27/10 - 09/26/15

NIAID/NIH
Human Hepatitis B Virus (HBV) Mouse Models for Testing HBV Therapeutics

HHSN272201000039I, Task A15 (J. Morrey - PI)

09/27/10 - 09/26/15

NIAID/NIH
Mouse Models for Evaluation of Influenza Vaccines and Adjuvants

2U54 AI065357/ Sub-award G-7820-1 (J. Morrey - PI)

05/01/09 - 04/30/14

Rocky Mountain RCE/NIAID/NIH
Treatment of Acute West Nile Virus Disease and Neurological Sequelae

2U54 AI065357/ Sub-award G-7822-1 (B. Gowen - PI)

05/01/09 - 04/30/14

Rocky Mountain RCE/NIAID/NIH
T-705 Pyrazine Derivative Treatment of Highly Pathogenic Arenaviral Infections

HHSN272201000039I, Task A56 (J. Morrey - PI)

09/090/13 - 09/08/14

NIAID/NIH
Mouse Models for Low Pathogenic Seasonal and Pandemic Influenza

HHSN272201000039I, Task A57 (J. Morrey - PI)

09/15/13 - 03/14/15

NIAID/NIH
Mouse Models of Medical Countermeasures Against Middle East Respiratory
Syndrome Coronavirus (MERS-CoV)

HHSN272201100019I, Task B01 (D. Smee - PI)

9/30/11 - 9/29/12

NIAID/NIH
In Vitro Assessment for Antimicrobial Activity

HHSN272201100019I, Task B13 (D. Smee - PI)

9/01/13 - 08/31/14

NIAID/NIH
In Vitro Assessment for Antimicrobial Activity Against Respiratory Virusess  

1R21AI101483-01 (J. Morrey - PI)

06/01/12 - 05/31/14

NIAID/NIH
Targeting Induction of Cytosolic Calcium Buffers for Treatment of Viral Encephalitis

2R44AI092916-02 (B. Tarbet - PI)

07/01/12 - 6/30/14

NIAID/NIH
Robust, Defined, Animal-Free Cell Culture Medium for the Production of Vaccines

 
#theTemplate.getDirectEidtLink()#